What is the current price of the 2228.HK stock and recent movement?

2228.HK stock closed at **HK$11.37** on 11 Feb 2026, up **0.08** or **0.71%** for the session, with volume **43,290,767.00** shares and a year high of **HK$15.12**.

What are the main valuation metrics for XtalPi (2228.HK)?

Key metrics: EPS **HK$1.05**, reported PE **10.86**, PB **5.42**, price-to-sales near **63.66**, and book value per share **HK$1.87**. These indicate high growth expectations.

What forecast does Meyka AI provide for 2228.HK stock?

Meyka AI's forecast model projects a monthly **HK$14.10** target and a yearly **HK$10.47** projection. Forecasts are model-based and not guarantees; they show scenario upside and downside.

When is the next earnings report for XtalPi on HKSE?

XtalPi’s next earnings announcement is scheduled for **2026-03-27**. Investors should watch revenue growth and cash flow metrics in that report for trading signals.

HK Stocks

HK$11.37 close for XtalPi 2228.HK on 11 Feb 2026: AI drug discovery outlook

ByDanny Kontos February 11, 2026February 11, 2026

The 2228.HK stock closed at HK$11.37 on 11 Feb 2026, up 0.08 or 0.71% for the session in Hong Kong (HKSE). Trading volume reached 43,290,767.00 shares, and the stock traded between HK$11.23 and HK$11.53 today. XtalPi Holdings Ltd (2228.HK) remains an AI-first drug discovery and automation company. We assess valuation, technical momentum, and near-term catalysts, and we link recent market moves to earnings and sector trends in Hong Kong healthtech.